Neoadjuvant Chemoradiotherapy vesus Chemotherapy alone Followed by Surgery for Resectable Stage III Non-Small-Cell Lung Cancer: a Meta-Analysis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/srep34388.pdf
Reference34 articles.
1. Yang, P. et al. Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. Chest 128, 452–462 (2005).
2. Riquet, M. et al. Long-term survival with surgery as part of a multimodality approach for N3 lung cancer. Eur J Cardiothorac Surg 44, 1117 (2013).
3. Nakamura, H., Kawasaki, N., Taguchi, M. & Kabasawa, K. Role of preoperative chemotherapy for non-small-cell lung cancer: a meta-analysis. Lung Cancer 54, 325–329 (2006).
4. Seder, C. W. et al. Stage IIIA Non-Small Cell Lung Cancer: Morbidity and Mortality of Three Distinct Multimodality Regimens. Ann Thorac Surg 95, 1708–1716 (2013).
5. Shah, A. A. et al. Induction chemoradiation is not superior to induction chemotherapy alone in stage IIIA lung cancer. Ann Thorac Surg 93, 1807–1812 (2012).
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Optimization of diagnostic and therapeutic management in patients with stage III non-small cell lung cancer — experience of the centers in Poznań;Oncology in Clinical Practice;2023-06-29
2. Clinical management of stage III non‐small cell lung cancer in India: An expert consensus statement;Asia-Pacific Journal of Clinical Oncology;2023-02-23
3. LIFE EXPECTANCY IN PATIENTS WITH STAGE III A NON-SMALL CELL LUNG CANCER (NSCLC) TREATED WITH NEOADJUVANT CHEMORADIOTHERAPY (NCRT), NEOADJUVANT CHEMOTHERAPY (NCT), NEOADJUVANT CHEMOTHERAPY + ADJUVANT RADIATION THERAPY (NCT + ADJUVANT RT);Health Problems of Civilization;2022
4. Synchronous Esophageal and Lung Cancers—Is Combined Anatomic Resection Appropriate?;The Annals of Thoracic Surgery;2021-04
5. Clinical recommendations for perioperative immunotherapy‐induced adverse events in patients with non‐small cell lung cancer;Thoracic Cancer;2021-03-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3